Literature DB >> 11458069

Prevalence and bothersomeness of lower urinary tract symptoms in benign prostatic hyperplasia and their impact on well-being.

M D Eckhardt1, G E van Venrooij, H H van Melick, T A Boon.   

Abstract

PURPOSE: We established the prevalence and bothersomeness of symptoms and their impact on well-being in a large group of strictly selected men with lower urinary tract symptoms suggestive of benign prostatic hyperplasia (BPH).
MATERIALS AND METHODS: Included in our study were 475 consecutive men who met the criteria of the International Consensus Committee on BPH and voided more than 150 ml. during uroflowmetry. International Prostate Symptom Scores and quality of life score were determined. We included the 7 bothersomeness questions of the Symptom Problem Index and the 4 of the BPH Impact Index of the American Urological Association Measurement Committee. These questions refer to the degree of bothersomeness caused by urinary problems and how they affect various health domains.
RESULTS: The symptoms with the highest prevalence based on mean scores were weak urinary stream, frequency and urgency. Urgency, nocturia and hesitancy were the most bothersome symptoms. Patients were only discouraged from performing normal daily activity when the symptom index exceeded 20. Incomplete emptying and frequency bothersomeness correlated strongly, and weak urinary stream and hesitancy bothersomeness correlated weakly with all health and quality of life domains.
CONCLUSIONS: Weak urinary stream, frequency and urgency were the most prevalent symptoms, while urgency, nocturia and hesitancy were the most bothersome symptoms. In contrast to weak urinary stream and hesitancy, the bothersomeness of incomplete emptying and frequency was strongly associated with well-being.

Entities:  

Mesh:

Year:  2001        PMID: 11458069

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  20 in total

Review 1.  Efficacy and safety of prostatic artery embolization for benign prostatic hyperplasia: a systematic review and meta-analysis of randomized controlled trials.

Authors:  Peng Xiang; Di Guan; Zhen Du; Yongxiu Hao; Wei Yan; Yonghui Wang; Yutong Liu; Dan Liu; Hao Ping
Journal:  Eur Radiol       Date:  2021-01-15       Impact factor: 5.315

2.  Long-lasting bladder overactivity and bladder afferent hyperexcitability in rats with chemically-induced prostatic inflammation.

Authors:  Jianshu Ni; Shinsuke Mizoguchi; Kyrie Bernardi; Takahisa Suzuki; Masahiro Kurobe; Eiichiro Takaoka; Zhou Wang; Donald B DeFranco; Pradeep Tyagi; Baojun Gu; Naoki Yoshimura
Journal:  Prostate       Date:  2019-03-22       Impact factor: 4.104

3.  Development of a quality of life scale specific for patients with benign prostatic hyperplasia.

Authors:  Kamil Cam; Talha Muezzinoglu; Omer Aydemir; Recep Buyukalpelli; Gokhan Toktas; Hakan Gemalmaz
Journal:  Int Urol Nephrol       Date:  2013-02-19       Impact factor: 2.370

4.  The urologist's view of male overactive bladder: discrepancy between reality and belief in practical setting.

Authors:  Seung Hwan Lee; Dae Kyung Kim; Joon Chul Kim; Kyu-Sung Lee; Jeong Gu Lee; Choal Hee Park; Sung Joon Hong; Choung-Soo Kim; Jong Kwan Park; Byung Ha Chung
Journal:  Yonsei Med J       Date:  2010-05       Impact factor: 2.759

5.  Strong impact of nocturia on sleep quality in patients with lower urinary tract symptoms.

Authors:  Seung Whan Doo; Hong Jun Lee; Jin Ahn; Jae Heon Kim; Jong Hyun Yun; Won Jae Yang; Yun Seob Song
Journal:  World J Mens Health       Date:  2012-08-31       Impact factor: 5.400

6.  Cross-cultural differences for adapting overactive bladder symptoms: results of an epidemiologic survey in Korea.

Authors:  Myung-Soo Choo; Ja Hyeon Ku; Jong Bok Lee; Dong Hwan Lee; Joon Chul Kim; Hyung-Jee Kim; Jeong Ju Lee; Won-Hee Park
Journal:  World J Urol       Date:  2007-06-14       Impact factor: 4.226

7.  Prostatic artery embolization in benign prostatic hyperplasia: preliminary results in 13 patients.

Authors:  Maurizio Grosso; Alberto Balderi; Matteo Arnò; Davide Sortino; Alberto Antonietti; Fulvio Pedrazzini; Grazia Giovinazzo; Claudia Vinay; Orazio Maugeri; Carlo Ambruosi; Giuseppe Arena
Journal:  Radiol Med       Date:  2014-09-23       Impact factor: 3.469

8.  Superselective α-adrenergic blockers versus transurethral resection of the prostate: a prospective comparison of health-related quality of life outcome after treating patients with benign prostatic hyperplasia.

Authors:  Negin Hadi; Alireza Aminsharifi; Ali Sadeghi; Ali Tourchi
Journal:  Qual Life Res       Date:  2012-09-05       Impact factor: 4.147

9.  Novel non-invasive biomarkers that distinguish between benign prostate hyperplasia and prostate cancer.

Authors:  Andrej Jedinak; Adam Curatolo; David Zurakowski; Simon Dillon; Manoj K Bhasin; Towia A Libermann; Roopali Roy; Monisha Sachdev; Kevin R Loughlin; Marsha A Moses
Journal:  BMC Cancer       Date:  2015-04-11       Impact factor: 4.430

10.  Is absorption of irrigation fluid a problem in Thulium laser vaporization of the prostate? A prospective investigation using the expired breath ethanol test.

Authors:  Livio Mordasini; Dominik Abt; Gautier Müllhaupt; Daniel S Engeler; Andreas Lüthi; Hans-Peter Schmid; Christoph Schwab
Journal:  BMC Urol       Date:  2015-04-24       Impact factor: 2.264

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.